Menatetrenone Completed Phase 4 Trials for Osteoporosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00548509The Effect of Vitamin K2 on Bone Turnover